Radiotherapy plus cetuximab for locally advanced squamous cell head and neck cancer in patients with cisplatin-ineligible renal dysfunction: A retrospective study.

Oncol Lett · 2022 · PMC9258593 · PMID 35836484

Europe PMC DOI

hedged sentence

0.0860

closest p · 1.7× alpha

0.0860

boldest claim

The sentences

marginally significantP=0.086so close (0.05 < p ≤ 0.1)

CrCl <45 ml/min tended to be a marginally significant adverse prognostic factor (HR 2.45, 95% CI 0.88-6.83; P=0.086).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.